{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:43:33Z","timestamp":1794447813337,"version":"4.9.1"},"reference-count":50,"publisher":"American Chemical Society (ACS)","issue":"12","license":[{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100009888","name":"Regione Toscana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Infantile neural ceroid lipofuscinosis (INCL) is a lysosomal storage disorder characterized by mutations in the CLN1 gene that leads to lack of the lysosomal enzyme palmitoyl-protein thioesterase-1 (PPT1), which causes the progressive death of cortical neurons. Enzyme replacement therapy (ERT) is one of the most promising treatments, but its translation toward a clinical use is hampered by the need to deliver the enzyme to the central nervous system and a more detailed understanding of its capability to restore physiologic conditions at the biochemical and protein level, beyond the simple regulation of enzymatic activity. Targeted nanoparticles can promote protein delivery to the central nervous system and affect biological pathways inside cells. Here, we describe an innovative peptide-based stealth nanoparticle that inhibits serum protein adsorption exploiting transferrin-driven internalization to convey the PPT1 enzyme to transferrin receptor-mediated pathways (endocytosis in this work, or transcytosis, in perspective, in vivo). These enzyme-loaded nanoparticles were able to restore stable levels of enzymatic activity in CLN1 patient\u2019s fibroblasts, comparable with the free enzyme, demonstrating that delivery after encapsulation in the nanocarrier does not alter uptake or intracellular trafficking. We also investigate, for the first time, dysregulated pathways of proteome and palmitoylome and their alteration upon enzyme delivery. Our nanoparticles were able of halving palmitoylated protein levels restoring conditions similar to the normal cells. From proteomic analysis, we also highlighted the reduction of the different groups of proteins after treatments with the free or encapsulated enzyme. In conclusion, our system is able to deliver the enzyme to a model of CLN1 disease restoring normal conditions in cells. Investigation of molecular details of pathologic state and enzyme-based correction reveals dysregulated pathways with unprecedented details for CLN1. Finally, we unveil for the first time the dysregulation landscape of palmitoylome and proteome in primary patient-derived fibroblasts and their modifications in response to enzyme administration. These findings will provide a guideline for the validation of future therapeutic strategies based on enzyme replacement therapy or acting at different metabolic levels.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.0c00615","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T15:01:05Z","timestamp":1603897265000},"page":"4510-4521","source":"Crossref","is-referenced-by-count":20,"title":["Protein Delivery by Peptide-Based Stealth Liposomes:\nA Biomolecular Insight into Enzyme Replacement Therapy"],"prefix":"10.1021","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9374-883X","authenticated-orcid":true,"given":"Melissa","family":"Santi","sequence":"first","affiliation":[{"name":"Center for Nanotechnology Innovation@NEST, Istituto Italiano di Tecnologia , ,","place":["Pisa, Italy, 56127"]},{"name":"NEST, Scuola Normale Superiore and Istituto Nanoscienze-CNR , ,","place":["Pisa, Italy, 56127"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Finamore","sequence":"additional","affiliation":[{"name":"Institute of Clinical Physiology-CNR , ,","place":["Pisa, Italy, 56127"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Cecchettini","sequence":"additional","affiliation":[{"name":"University of Pisa, Dept. of Clinical and Experimental Medicine , ,","place":["Pisa, Italy, 56126"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo Maria","family":"Santorelli","sequence":"additional","affiliation":[{"name":"Molecular Medicine, IRCCS Stella Maris , ,","place":["Pisa, Italy, 56128"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Doccini","sequence":"additional","affiliation":[{"name":"Molecular Medicine, IRCCS Stella Maris , ,","place":["Pisa, Italy, 56128"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Rocchiccioli","sequence":"additional","affiliation":[{"name":"Institute of Clinical Physiology-CNR , ,","place":["Pisa, Italy, 56127"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Signore","sequence":"additional","affiliation":[{"name":"NEST, Scuola Normale Superiore and Istituto Nanoscienze-CNR , ,","place":["Pisa, Italy, 56127"]},{"name":"Fondazione Pisana per la Scienza , ,","place":["Pisa, Italy, 56017"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2020,10,28]]},"reference":[{"key":"2026081418203128400_cit1","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.nbd.2004.02.010","article-title":"Regional and Cellular\nNeuropathology in the Palmitoyl Protein Thioesterase-1 Null Mutant\nMouse Model of Infantile Neuronal Ceroid Lipofuscinosis","volume":"16","author":"Bible","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"2026081418203128400_cit2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/01.wco.0000063762.15877.9b","article-title":"Progress\ntowards Understanding the Neurobiology of Batten Disease or Neuronal\nCeroid Lipofuscinosis","volume":"16","author":"Cooper","year":"2003","journal-title":"Curr. Opin. Neurol."},{"key":"2026081418203128400_cit3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/019131201300004681","article-title":"Neuronal Ceroid Lipofuscinosis:\nAn Ultrastructural, Genetic, and Clinical Study Report","volume":"25","author":"Boldrini","year":"2009","journal-title":"Ultrastruct. Pathol."},{"key":"2026081418203128400_cit4","doi-asserted-by":"publisher","first-page":"15831","DOI":"10.1074\/jbc.271.26.15831","article-title":"Lysosomal Targeting\nof Palmitoyl-Protein Thioesterase","volume":"271","author":"Verkruyse","year":"1996","journal-title":"J. Biol.\nChem."},{"key":"2026081418203128400_cit5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.nbd.2007.06.012","article-title":"Palmitoyl\nProtein Thioesterase 1 (Ppt1)-Deficient Mouse Neurons Show Alterations\nin Cholesterol Metabolism and Calcium Homeostasis Prior to Synaptic\nDysfunction","volume":"28","author":"Ahtiainen","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"2026081418203128400_cit6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0304-3835(02)00403-2","article-title":"Anti-Tumor\nPromoting\nEffects of Palmitoyl: Protein Thioesterase Inhibitors against a Human\nNeurotumor Cell Line","volume":"187","author":"Dawson","year":"2002","journal-title":"Cancer Lett."},{"key":"2026081418203128400_cit7","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1007\/BF00711520","article-title":"Long-Term\nClinical Progress in Bone Marrow Transplanted Mucopolysaccharidosis\nType I Patients with a Defined Genotype","volume":"16","author":"Hopwood","year":"1993","journal-title":"J.\nInherited Metab. Dis."},{"key":"2026081418203128400_cit8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.nbd.2004.03.005","article-title":"Adeno-Associated\nVirus 2-Mediated\nGene Therapy Decreases Autofluorescent Storage Material and Increases\nBrain Mass in a Murine Model of Infantile Neuronal Ceroid Lipofuscinosis","volume":"16","author":"Griffey","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"2026081418203128400_cit9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1042\/bj3570049","article-title":"Production and Characterization\nof Recombinant Human CLN2 Protein for Enzyme-Replacement\nTherapy in Late Infantile Neuronal\nCeroid Lipofuscinosis","volume":"357","author":"Lin","year":"2001","journal-title":"Biochem. J."},{"key":"2026081418203128400_cit10","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1021\/acs.bioconjchem.8b00206","article-title":"Cross-Linked Enzyme Aggregates as\nVersatile Tool for Enzyme Delivery: Application to Polymeric Nanoparticles","author":"Galliani","year":"2018","journal-title":"Bioconjugate Chem."},{"key":"2026081418203128400_cit11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00439-006-0280-4","article-title":"New Therapeutic\nOptions for Lysosomal Storage Disorders: Enzyme Replacement, Small\nMolecules and Gene Therapy","volume":"121","author":"Beck","year":"2007","journal-title":"Hum. Genet."},{"key":"2026081418203128400_cit12","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ymgme.2009.12.002","article-title":"Human Recombinant\nPalmitoyl-Protein Thioesterase-1\n(PPT1) for Preclinical Evaluation of Enzyme Replacement Therapy for\nInfantile Neuronal Ceroid Lipofuscinosis","volume":"99","author":"Lu","year":"2010","journal-title":"Mol.\nGenet. Metab."},{"key":"2026081418203128400_cit13","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","article-title":"Study\nof Intraventricular\nCerliponase Alfa for CLN2 Disease","volume":"378","author":"Schulz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"2026081418203128400_cit14","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1039\/C7TB00244K","article-title":"Silica-Based Nanoparticles for Therapeutic\nProtein Delivery","volume":"5","author":"Yu","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"2026081418203128400_cit15","first-page":"135","article-title":"Targeted Drug Delivery System : A Review","volume":"1","author":"Manish","year":"2011","journal-title":"Res. J. Chem. Sci."},{"key":"2026081418203128400_cit16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","article-title":"Nanoparticle-Based Targeted Drug\nDelivery","volume":"86","author":"Singh","year":"2009","journal-title":"Exp. Mol. Pathol."},{"key":"2026081418203128400_cit17","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax7462","article-title":"Brain-Targeted\nEnzyme-Loaded Nanoparticles: A Breach through the Blood-Brain Barrier\nfor Enzyme Replacement Therapy in Krabbe Disease","volume":"5","author":"Del\nGrosso","year":"2019","journal-title":"Sci. Adv."},{"key":"2026081418203128400_cit18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/jnr.490180206","article-title":"Receptor-Mediated\nTranscytosis of Transferrin across the Blood-Brain Barrier","volume":"18","author":"Fishman","year":"1987","journal-title":"J. Neurosci. Res."},{"key":"2026081418203128400_cit19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejpb.2008.08.021","article-title":"Transferrin- and Transferrin-Receptor-Antibody-Modified\nNanoparticles Enable Drug Delivery across the Blood-Brain Barrier\n(BBB)","volume":"71","author":"Ulbrich","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"2026081418203128400_cit20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.nbd.2009.07.028","article-title":"Approaches\nto Transport Therapeutic Drugs across the Blood-Brain Barrier to Treat\nBrain Diseases","volume":"37","author":"Gabathuler","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"2026081418203128400_cit21","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1002\/jbm.a.36145","article-title":"Transferrin-Conjugated\nMagnetic Dextran-Spermine Nanoparticles for Targeted Drug Transport\nacross Blood-Brain Barrier","author":"Ghadiri","year":"2017","journal-title":"J. Biomed. Mater.\nRes., Part A"},{"key":"2026081418203128400_cit22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s13346-017-0368-5","article-title":"Development of Antibody-Modified\nChitosan Nanoparticles for the Targeted Delivery of SiRNA across the\nBlood-Brain Barrier as a Strategy for Inhibiting HIV Replication in\nAstrocytes","author":"Gu","year":"2017","journal-title":"Drug Delivery Transl. Res."},{"key":"2026081418203128400_cit23","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2015.9","article-title":"Aptamer-Mediated\nCodelivery of Doxorubicin\nand NF-\u03baB Decoy Enhances Chemosensitivity of Pancreatic Tumor\nCells","volume":"4","author":"Porciani","year":"2015","journal-title":"Mol. Ther.--Nucleic Acids"},{"key":"2026081418203128400_cit24","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2013.71","article-title":"Two Interconvertible Folds Modulate\nthe Activity of a DNA Aptamer Against Transferrin Receptor","volume":"3","author":"Porciani","year":"2014","journal-title":"Mol. Ther.--Nucleic Acids"},{"key":"2026081418203128400_cit25","doi-asserted-by":"publisher","first-page":"15908","DOI":"10.1073\/pnas.0808360105","article-title":"Aptamer-Based Endocytosis of a Lysosomal Enzyme","volume":"105","author":"Chen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026081418203128400_cit26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nnano.2012.237","article-title":"Transferrin-Functionalized Nanoparticles\nLose Their Targeting Capabilities When a Biomolecule Corona Adsorbs\non the Surface","volume":"8","author":"Salvati","year":"2013","journal-title":"Nat. Nanotechnol."},{"key":"2026081418203128400_cit27","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0169-409X(02)00226-0","article-title":"PEGylated Nanoparticles for Biological\nand Pharmaceutical Applications","volume":"55","author":"Otsuka","year":"2003","journal-title":"Adv. Drug Delivery\nRev."},{"key":"2026081418203128400_cit28","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1002\/smll.201303540","article-title":"Zwitterionic-Coated\n\u201cStealth\u201d Nanoparticles for Biomedical Applications:\nRecent Advances in Countering Biomolecular Corona Formation and Uptake\nby the Mononuclear Phagocyte System","volume":"10","author":"Garci\u0301a","year":"2014","journal-title":"Small"},{"key":"2026081418203128400_cit29","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1021\/acs.bioconjchem.6b00701","article-title":"Peptide-Based\nStealth Nanoparticles\nfor Targeted and PH-Triggered Delivery","volume":"28","author":"Ranalli","year":"2017","journal-title":"Bioconjugate\nChem."},{"key":"2026081418203128400_cit30","doi-asserted-by":"publisher","first-page":"13171","DOI":"10.1021\/am404171h","article-title":"Selective\nTargeting Capability Acquired\nwith a Protein Corona Adsorbed on the Surface of 1,2-Dioleoyl-3-Trimethylammonium\nPropane\/Dna Nanoparticles","volume":"5","author":"Caracciolo","year":"2013","journal-title":"ACS Appl. Mater.\nInterfaces"},{"key":"2026081418203128400_cit31","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1021\/acs.bioconjchem.6b00611","article-title":"Rational Design of\na Transferrin-Binding Peptide Sequence Tailored to Targeted Nanoparticle\nInternalization","volume":"28","author":"Santi","year":"2016","journal-title":"Bioconjugate Chem."},{"key":"2026081418203128400_cit32","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2147\/IJN.S68861","article-title":"Liposomes as Nanomedical\nDevices","volume":"10","author":"Bozzuto","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"2026081418203128400_cit33","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1166\/jnn.2014.9080","article-title":"Liposomes: Versatile\nand Biocompatible Nanovesicles\nfor Efficient Biomolecules Delivery","author":"Mallick","year":"2014","journal-title":"J. Nanosci.\nNanotechnol."},{"key":"2026081418203128400_cit34","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1006\/mgme.1999.2809","article-title":"A Rapid Fluorogenic Palmitoyl-Protein Thioesterase\nAssay: Pre- and Postnatal Diagnosis of INCL","volume":"66","author":"van\nDiggelen","year":"1999","journal-title":"Mol. Genet. Metab."},{"key":"2026081418203128400_cit35","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/nprot.2007.225","article-title":"Palmitoylated Proteins:\nPurification and Identification","volume":"2","author":"Wan","year":"2007","journal-title":"Nat. Protoc."},{"key":"2026081418203128400_cit36","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/978-1-60761-444-9_15","article-title":"Trans-Proteomic\nPipeline: A Pipeline for Proteomic Analysis","volume-title":"Proteome Bioinformatics","author":"Pedrioli","year":"2010"},{"key":"2026081418203128400_cit37","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/cgt.2013.9","article-title":"Transferrin\nReceptor Targeting Nanomedicine Delivering Wild-Type P53 Gene Sensitizes\nPancreatic Cancer to Gemcitabine Therapy","volume":"20","author":"Camp","year":"2013","journal-title":"Cancer\nGene Ther."},{"key":"2026081418203128400_cit38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1472-6750-2-9","article-title":"Protein Encapsulation\nin Liposomes: Efficiency Depends on Interactions between Protein and\nPhospholipid Bilayer","volume":"2","author":"Colletier","year":"2002","journal-title":"BMC Biotechnol."},{"key":"2026081418203128400_cit39","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1021\/bp0201004","article-title":"Effective\nEncapsulation of Proteins into Size-Controlled Phospholipid Vesicles\nUsing Freeze-Thawing and Extrusion","volume":"19","author":"Sou","year":"2003","journal-title":"Biotechnol.\nProg."},{"key":"2026081418203128400_cit40","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrm3151","article-title":"Molecular Mechanism\nand Physiological Functions of\nClathrin-Mediated Endocytosis","volume":"12","author":"McMahon","year":"2011","journal-title":"Nat. Rev. Mol.\nCell Biol."},{"key":"2026081418203128400_cit41","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/mt.2008.9","article-title":"Intraventricular\nEnzyme Replacement Improves Disease Phenotypes in a Mouse Model of\nLate Infantile Neuronal Ceroid Lipofuscinosis","volume":"16","author":"Chang","year":"2008","journal-title":"Mol. Ther."},{"key":"2026081418203128400_cit42","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: A Cytoscape Plug-in to Decipher\nFunctionally Grouped Gene Ontology and Pathway Annotation Networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"key":"2026081418203128400_cit43","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.17","article-title":"S-Palmitoylation\nRepresents a Novel Mechanism Regulating the Mitochondrial Targeting\nof BAX and Initiation of Apoptosis","volume":"5","author":"Fro\u0308hlich","year":"2014","journal-title":"Cell Death\nDis."},{"key":"2026081418203128400_cit44","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1046\/j.1471-4159.2000.0741478.x","article-title":"Palmitoyl Protein Thioesterase 1 Protects against Apoptosis\nMediated by Ras-Akt-Caspase Pathway in Neuroblastoma Cells","volume":"74","author":"Cho","year":"2000","journal-title":"J. Neurochem."},{"key":"2026081418203128400_cit45","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1021\/acs.molpharmaceut.5b00542","article-title":"A Comparative\nStudy on the Alterations of Endocytic Pathways in Multiple Lysosomal\nStorage Disorders","volume":"13","author":"Rappaport","year":"2016","journal-title":"Mol. Pharmaceutics"},{"key":"2026081418203128400_cit46","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fnmol.2017.00266","article-title":"The\nNetworks of Genes\nEncoding Palmitoylated Proteins in Axonal and Synaptic Compartments\nAre Affected in PPT1 Overexpressing Neuronal-Like Cells","volume":"10","author":"Pezzini","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"2026081418203128400_cit47","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1093\/hmg\/ddh308","article-title":"Filamin C Interacts with the Muscular\nDystrophy KY Protein and Is Abnormally Distributed in Mouse KY Deficient\nMuscle Fibres","volume":"13","author":"Beatham","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"2026081418203128400_cit48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00401-012-1054-9","article-title":"Filamin C-Related Myopathies: Pathology and Mechanisms","author":"Fu\u0308rst","year":"2013","journal-title":"Acta Neuropathol."},{"key":"2026081418203128400_cit49","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40478-015-0246-7","article-title":"Investigating\nthe Role of Filamin C in Belgian Patients with Frontotemporal Dementia\nLinked to GRN Deficiency in FTLD-TDP Brains","volume":"3","author":"Janssens","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"2026081418203128400_cit50","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/jnc.12460","article-title":"Genomic Editing Opens\nNew Avenues for Zebrafish as a Model for Neurodegeneration","volume":"127","author":"Schmid","year":"2013","journal-title":"J. Neurochem."}],"container-title":["Molecular\nPharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.0c00615","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/17\/12\/4510\/13657536\/mp0c00615.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/17\/12\/4510\/13657536\/mp0c00615.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T22:26:12Z","timestamp":1786746372000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/17\/12\/4510\/510178\/Protein-Delivery-by-Peptide-Based-Stealth"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,28]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,10,28]]},"published-print":{"date-parts":[[2020,12,7]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00615","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00615.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00615.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00615.s003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00615.s004","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00615.s005","asserted-by":"subject"}]},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,28]]}}}